Skip to content

Insulin Resistance in Idiopathic Oligospermia and Azoospermia

Insulin Resistance : a New Diagnosis of the Pathogenesis of Idiopathic Oligozoospermia and Non Obstructive Azoospermia

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01509482
Enrollment
100
Registered
2012-01-13
Start date
2012-01-31
Completion date
2014-04-30
Last updated
2014-11-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Azoospermia, Insulin Resistance, Oligospermia

Keywords

insulin resistance, unexplained azoospermia, unexplained oligospermia

Brief summary

Insulin resistance in men can be the underlying major factor in reproductive abnormalities ( chronic hypospermatogenesis ) as well as metabolic abnormalities similar to polycystic ovarian syndrome ( PCOS ) in women.

Detailed description

During the past decade IR has been recognized as a major contributor to the pathogenesis of chronic anovulation, hyperandrogenism and metabolic abnormalities associated with PCOS . Theoretically IR in men may result in a similar reproductive abnormalities ( chronic hypospermatogenesis ) as well as other metabolic abnormalities similar to what happens in PCOS in women .

Interventions

OTHERblood samples

blood samples to test for primary and secondary outcome measures

OTHERBlood samples

IR Cholesterol HDL LDL Fasting Glucose Triglycerides

Sponsors

The Egyptian IVF-ET Center
Lead SponsorOTHER

Study design

Allocation
NON_RANDOMIZED
Intervention model
PARALLEL
Primary purpose
DIAGNOSTIC
Masking
NONE

Eligibility

Sex/Gender
MALE
Age
25 Years to 55 Years
Healthy volunteers
Yes

Inclusion criteria

* sperm count less than 10 million per milliliter * non-obstructive azoospermia

Exclusion criteria

* high FSH ( \> 10 mIU/ ml ) * high prolactin ( \> 36 mIU/ml ) * abnormal karyotype * AZF

Design outcomes

Primary

MeasureTime frame
serum insulinone month

Secondary

MeasureTime frame
cholesterolone month
high density lipoprotein ( HDL)one month
Fasting Glucoseone month
testosteroneone month
TriglyceridesOne month
Low density lipoprotein ( LDL )one month

Countries

Egypt

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026